Lanean...
Novel regulation of checkpoint kinase 1: Is checkpoint kinase 1 a good candidate for anti‐cancer therapy?
DNA‐damaging strategies, such as radiotherapy and the majority of chemotherapeutic therapies, are the most frequently used non‐surgical anti‐cancer therapies for human cancers. These therapies activate DNA damage/replication checkpoints, which induce cell‐cycle arrest to provide the time needed to r...
Gorde:
| Argitaratua izan da: | Cancer Sci |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2012
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7659239/ https://ncbi.nlm.nih.gov/pubmed/22435685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02280.x |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|